--- title: Blog description: Blog --- [![UBC](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-white.png?width=175&name=logo-white.png "UBC")](https://ubc.com/) - [Home](https://ubc.com/) - Services - [Full-Service Clinical Development](https://ubc.com/global-services/) - [Clinical Trial Management & Late Stage Research](https://ubc.com/global-services/trials-and-research/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/global-services/decentralized/) - [Patient & Physician Services](https://ubc.com/global-services/pps/) - [Pharmacovigilance](https://ubc.com/global-services/pharmacovigilance/) - [Risk Management Plans](https://ubc.com/global-services/risk-management/) - [Risk Evaluation and Mitigation Strategies (REMS)](https://ubc.com/global-services/rems/) - [Registries & Observational Studies](https://ubc.com/global-services/registries/) - [Safety & Epidemiology Consulting](https://ubc.com/global-services/epidemiology/) - [Become a Clinical Trial Investigator](https://ubc.com/global-services/become-an-investigator/) - [Patient Support Services](https://ubc.com/patient-support/) - [Access Services](https://ubc.com/patient-support/access-services/) - [Clinical Education](https://ubc.com/patient-support/clinical-education/) - [Connected Health](https://ubc.com/patient-support/connected-health/) - [In-Home Care Coordination](https://ubc.com/patient-support/care-coordination/) - [In-Workflow Services](https://ubc.com/patient-support/in-workflow-services/) - [Outcomes and Value](https://ubc.com/patient-support/outcomes-and-value/) - [Patient Engagement](https://ubc.com/patient-support/patient-engagement/) - [Real World Evidence](https://ubc.com/real-world-evidence/) - [RWE Consulting Practice](https://ubc.com/real-world-evidence/rwe-consulting/) - [Real World Data](https://ubc.com/real-world-evidence/real-world-data/) - [Mosaic Technology Platform](https://ubc.com/real-world-evidence/mosaic-technology-platform/) - [Automated Analytics Software](https://ubc.com/real-world-evidence/analytics-software/) - [Product Lifecycle Solutions](https://ubc.com/product-lifecycle/) - [Cell & Gene Therapy](https://ubc.com/product-lifecycle/cell-gene/) - [COVID-19](https://ubc.com/product-lifecycle/patient-care/) - [Oncology](https://ubc.com/product-lifecycle/oncology/) - [Nursing](https://ubc.com/product-lifecycle/nursing/) - [Rare Disease](https://ubc.com/product-lifecycle/rare-disease/) - [Technology](https://ubc.com/technology/) - [Automated Analytics Software](https://ubc.com/technology/automated-analytics-software/) - [Connected Health](https://ubc.com/technology/connected-health/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/technology/decentralized-studies-virtual-engagement/) - [Mosaic Technology Platform](https://ubc.com/technology/mosaic-technology-platform/) - [Patient Engagement](https://ubc.com/technology/engage/) - [Think Tank](https://blog.ubc.com/blog) - About - [About UBC](https://ubc.com/about/) - [Awards](https://ubc.com/about/awards/) - [Leadership Team](https://ubc.com/about/leadership/) - [Press Releases](https://ubc.com/about/press/) - [Careers](https://ubc.com/careers/) [SUBMIT RFI/RFP](https://ubc.com/contact/) Menu [![UBC](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-white.png?width=175&name=logo-white.png "UBC")](https://ubc.com/) - [Home](https://ubc.com/) - Services - [Full-Service Clinical Development](https://ubc.com/global-services/) - [Clinical Trial Management & Late Stage Research](https://ubc.com/global-services/trials-and-research/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/global-services/decentralized/) - [Patient & Physician Services](https://ubc.com/global-services/pps/) - [Pharmacovigilance](https://ubc.com/global-services/pharmacovigilance/) - [Risk Management Plans](https://ubc.com/global-services/risk-management/) - [Risk Evaluation and Mitigation Strategies (REMS)](https://ubc.com/global-services/rems/) - [Registries & Observational Studies](https://ubc.com/global-services/registries/) - [Safety & Epidemiology Consulting](https://ubc.com/global-services/epidemiology/) - [Become a Clinical Trial Investigator](https://ubc.com/global-services/become-an-investigator/) - [Patient Support Services](https://ubc.com/patient-support/) - [Access Services](https://ubc.com/patient-support/access-services/) - [Clinical Education](https://ubc.com/patient-support/clinical-education/) - [Connected Health](https://ubc.com/patient-support/connected-health/) - [In-Home Care Coordination](https://ubc.com/patient-support/care-coordination/) - [In-Workflow Services](https://ubc.com/patient-support/in-workflow-services/) - [Outcomes and Value](https://ubc.com/patient-support/outcomes-and-value/) - [Patient Engagement](https://ubc.com/patient-support/patient-engagement/) - [Real World Evidence](https://ubc.com/real-world-evidence/) - [RWE Consulting Practice](https://ubc.com/real-world-evidence/rwe-consulting/) - [Real World Data](https://ubc.com/real-world-evidence/real-world-data/) - [Mosaic Technology Platform](https://ubc.com/real-world-evidence/mosaic-technology-platform/) - [Automated Analytics Software](https://ubc.com/real-world-evidence/analytics-software/) - [Product Lifecycle Solutions](https://ubc.com/product-lifecycle/) - [Cell & Gene Therapy](https://ubc.com/product-lifecycle/cell-gene/) - [COVID-19](https://ubc.com/product-lifecycle/patient-care/) - [Oncology](https://ubc.com/product-lifecycle/oncology/) - [Nursing](https://ubc.com/product-lifecycle/nursing/) - [Rare Disease](https://ubc.com/product-lifecycle/rare-disease/) - [Technology](https://ubc.com/technology/) - [Automated Analytics Software](https://ubc.com/technology/automated-analytics-software/) - [Connected Health](https://ubc.com/technology/connected-health/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/technology/decentralized-studies-virtual-engagement/) - [Mosaic Technology Platform](https://ubc.com/technology/mosaic-technology-platform/) - [Patient Engagement](https://ubc.com/technology/engage/) - [Think Tank](https://blog.ubc.com/blog) - About - [About UBC](https://ubc.com/about/) - [Awards](https://ubc.com/about/awards/) - [Leadership Team](https://ubc.com/about/leadership/) - [Press Releases](https://ubc.com/about/press/) - [Careers](https://ubc.com/careers/) - [Submit RFI/RFP](https://ubc.com/contact/) [UBC](https://ubc.com) /Blog ## Featured Content ### Planning for Diversity in Clinical Trials UBC is grateful to be able to play a role in proving the safety and efficacy of therapies in clinical trials. We are also grateful for all the... [Read More](https://blog.ubc.com/blog/planning-for-diversity-in-clinical-trials) Content Type **No** filters applied No filters applied filters applied Clear all - All - Blog - Case Study - Press - Video - Webinar - Whitepapers Showing 1 of 42 Stories #### [Planning for Diversity in Clinical Trials](https://blog.ubc.com/blog/planning-for-diversity-in-clinical-trials) December 5, 2022 UBC is grateful to be able to play a role in proving the safety and efficacy of therapies in clinical trials. We are also grateful for all the fantastic partners and... [Read More](https://blog.ubc.com/blog/planning-for-diversity-in-clinical-trials) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Practical Considerations for Evidence Generation](https://blog.ubc.com/blog/practical-considerations-rwe) November 23, 2022 It is critical to know the audience and needed endpoints for research. This will inform what evidence is generated and what process are followed to ensure maximum... [Read More](https://blog.ubc.com/blog/practical-considerations-rwe) #### [Supporting Patients and Families Through Case Management](https://blog.ubc.com/blog/supporting-patients-and-families-through-case-management) November 15, 2022 As most of us go about our everyday lives, we often don’t think about those that are living with a devastating illness. Those people and their families need support,... [Read More](https://blog.ubc.com/blog/supporting-patients-and-families-through-case-management) #### [The Critical Nature of In-Home Nursing](https://blog.ubc.com/blog/critical-nature-of-in-home-nursing) November 7, 2022 Coming out of the last 2 years, we can all agree that patient behavior has changed. Everyone is navigating more home-based services in their day-to-day lives, including... [Read More](https://blog.ubc.com/blog/critical-nature-of-in-home-nursing) #### [Advance Your Pharmacovigilance Services, Step by Step](https://blog.ubc.com/blog/advance-your-pharmacovigilance-services) November 7, 2022 An important start for modernizing safety operations is the need for a step-wise approach. Some may consider pharmacovigilance to be a commodity, with case processing... [Read More](https://blog.ubc.com/blog/advance-your-pharmacovigilance-services) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Data Considerations for Evidence Generation](https://blog.ubc.com/blog/data-considerations-rwe) October 31, 2022 The first step in designing a Real World Evidence generation program is to know what types of data are available and which types are most useful to answer a research... [Read More](https://blog.ubc.com/blog/data-considerations-rwe) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Technology Considerations for Evidence Generation](https://blog.ubc.com/blog/tech-considerations-rwe) October 24, 2022 Before you can generate effective real world evidence (RWE), you have to maximize the real world data you can ingest, warehouse, and analyze. Learn invaluable technology... [Read More](https://blog.ubc.com/blog/tech-considerations-rwe) #### [Efficient Technological Advancements for Your REMS Program](https://blog.ubc.com/blog/tech-advancements-for-rems-program) October 3, 2022 After 15 years, there is still continuous improvement that can be implemented for Risk Evaluation and Mitigation Strategy (REMS) design and operations. It is critical to... [Read More](https://blog.ubc.com/blog/tech-advancements-for-rems-program) #### [Patients First: How Advocacy Enables Success](https://blog.ubc.com/blog/patients-first-advocacy-enables-success) October 3, 2022 Throughout my career, I have prided myself on being able to support patients through their medication treatment journey. It is fulfilling each time to know that you are... [Read More](https://blog.ubc.com/blog/patients-first-advocacy-enables-success) #### [Hub Services, The Patient’s Advocate](https://blog.ubc.com/blog/hub-services-the-patients-advocate) October 3, 2022 You haven’t been feeling well for quite some time. You have always been a healthy individual, so you push through the first warning signs that something might be wrong... [Read More](https://blog.ubc.com/blog/hub-services-the-patients-advocate) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Using RWD for More Efficient Decisions in Clinical Research](https://blog.ubc.com/blog/rwd-for-efficient-decisions-in-clinical-research) September 28, 2022 Generating Real World Evidence of product safety and effectiveness is becoming more important when presenting evidence to regulators, payors, and in meeting... [Read More](https://blog.ubc.com/blog/rwd-for-efficient-decisions-in-clinical-research) #### [Keeping Pace with Patient Services Trends in 2022](https://blog.ubc.com/blog/patient-services-trends-in-2022) June 7, 2022 It is clear that we are amid unprecedented disruption and innovation in the patient services space. It’s an exciting time to be part of our industry with the evolving... [Read More](https://blog.ubc.com/blog/patient-services-trends-in-2022) #### [Patient Onboarding – Don’t Lose Them Before They’ve Started](https://blog.ubc.com/blog/patient-onboarding-best-practices) May 2, 2022 As a patient begins their journey on a new therapy, their experience with that medication can be impacted by the resources aligned to support the patient throughout... [Read More](https://blog.ubc.com/blog/patient-onboarding-best-practices) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Specialty Medications, Specialty Challenges: Selecting a Services Partner & Creating a Model to Optimize Patient Outcomes](https://blog.ubc.com/blog/specialty-medications-specialty-challenges) March 31, 2022 When it comes to experience with specialty medication support models within the industry, a few know a lot, some know more, most only know what they know, and no one... [Read More](https://blog.ubc.com/blog/specialty-medications-specialty-challenges) #### [REMS, a Collaborative Effort](https://blog.ubc.com/blog/rems-a-collaborative-effort) March 25, 2022 As we all strive to improve our safety and risk management activities, open and successful work with others is a key to developing effective programs and to gaining new... [Read More](https://blog.ubc.com/blog/rems-a-collaborative-effort) #### [Patient Engagement & Study Design Innovation: Takeaways from SCOPE 2022](https://blog.ubc.com/blog/patient-engagement-study-design-scope-2022) February 18, 2022 The Summit for Clinical Operations Executives is a premier event where leading industry innovators gather to share ideas and learn about the latest developments in... [Read More](https://blog.ubc.com/blog/patient-engagement-study-design-scope-2022) #### [Using Call Center Metrics to Optimize the Patient Experience](https://blog.ubc.com/blog/using-call-center-metrics-to-optimize-the-patient-experience) February 14, 2022 When you spend time on hold with your internet, cable, or wireless telephone provider, does a two-minute hold feel like a lifetime? You wait to get answers to your... [Read More](https://blog.ubc.com/blog/using-call-center-metrics-to-optimize-the-patient-experience) [Blog](https://blog.ubc.com/blog/tag/blog) #### [The Art of Successful Gene Therapy Launches](https://blog.ubc.com/blog/the-art-of-successful-gene-therapy-launches) October 19, 2021 The cellular and gene therapy development pipeline anticipates major transformations with hundreds of products moving forward toward approval. The 40 gene therapies... [Read More](https://blog.ubc.com/blog/the-art-of-successful-gene-therapy-launches) [Press](https://blog.ubc.com/blog/tag/press) #### [Driving Patient Adherence Through Nursing and Compassionate Connections](https://blog.ubc.com/blog/driving-patient-adherence) October 6, 2021 UBC’s Director of Commercial Strategy and Client Engagement Kelly Elio, RN was featured in the MM+M podcast. Kelly discussed the guiding principles that make a powerful... [Read More](https://blog.ubc.com/blog/driving-patient-adherence) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Breaking Down Patient Barriers to Therapy Through Mobile Messaging & Virtual Assistants](https://blog.ubc.com/blog/healthcare-virtual-assistants) September 7, 2021 Current State of Healthcare Technology It’s evident within our healthcare system just how challenging it can be for patients and families to receive information and... [Read More](https://blog.ubc.com/blog/healthcare-virtual-assistants) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Decentralized Research Playbook](https://blog.ubc.com/blog/decentralized-research-playbook) September 2, 2021 The UBC Decentralized Research Playbook is intended to help inform and offer a practical assessment method to our partners who are looking to most effectively leverage... [Read More](https://blog.ubc.com/blog/decentralized-research-playbook) [Blog](https://blog.ubc.com/blog/tag/blog) #### [The Future of Artificial Intelligence (AI) in Pharmacovigilance (PV): Six Key Principles from the World Health Organization (WHO) on the Use of AI In Healthcare](https://blog.ubc.com/blog/the-future-of-ai-in-pv) August 24, 2021 These days, more and more companies employ automation technology in pharmacovigilance processes. The resource-intensive industry of pharmacovigilance and clinical safety... [Read More](https://blog.ubc.com/blog/the-future-of-ai-in-pv) [Press](https://blog.ubc.com/blog/tag/press) #### [The Impact of Real World Data (RWD) on the Pharmaceutical Industry](https://blog.ubc.com/blog/the-impact-of-rwd) August 12, 2021 UBC recently discussed the impact of real world data on the pharmaceutical industry and how it will impact the future of drug development with International Clinical... [Read More](https://blog.ubc.com/blog/the-impact-of-rwd) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Effective Patient Engagement & Adherence: Do’s and Dont’s](https://blog.ubc.com/blog/engagement-and-adherence) July 30, 2021 Recently, I was asked to define the word adherence and what adherence meant to me. A somewhat simple ask, but as I thought about my response, I quickly came to realize... [Read More](https://blog.ubc.com/blog/engagement-and-adherence) [Press](https://blog.ubc.com/blog/tag/press) #### [UBC Partners with Surescripts to Provide In-Workflow Specialty Patient Enrollment to Improve Patient Outcomes](https://blog.ubc.com/blog/ubc-partners-surescripts-specialty-patient-enrollment) June 29, 2021 Surescripts Specialty Patient Enrollment service will enable UBC to offer in-workflow enrollment to healthcare providers, which will improve awareness and utilization of... [Read More](https://blog.ubc.com/blog/ubc-partners-surescripts-specialty-patient-enrollment) [Press](https://blog.ubc.com/blog/tag/press) #### [UBC’s Innovative Patient Recruitment Campaign Wins Award](https://blog.ubc.com/blog/mobile-patient-recruitment-wins-award) June 22, 2021 UBC recently won a 2021 Healthiverse Heroes award from DrFirst for an innovative patient recruitment solution. UBC leveraged mobile patient recruitment for a Phase III... [Read More](https://blog.ubc.com/blog/mobile-patient-recruitment-wins-award) [Blog](https://blog.ubc.com/blog/tag/blog) #### [The Value of Nursing in Clinical Care Coordination](https://blog.ubc.com/blog/clinical-nursing-care-coordination) May 12, 2021 The recent global health crisis changed the way in which patients participate in research, and gain access to and adhere to commercial therapies.Across the country... [Read More](https://blog.ubc.com/blog/clinical-nursing-care-coordination) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Alleviating the Complexities of a Cell & Gene Therapy Program Through Patient Support](https://blog.ubc.com/blog/therapy-program-patient-support) April 14, 2021 There are individuals that are faced with devastating medical challenges every day. One example is people that have a gene or cell mutation in which a DNA gene or cell... [Read More](https://blog.ubc.com/blog/therapy-program-patient-support) [Press](https://blog.ubc.com/blog/tag/press) #### [Drive Engagement with Patients, Providers, and Your Brand](https://blog.ubc.com/blog/drive-engagement-with-patients) April 12, 2021 Ensuring Outcomes: New Ways to Drive Engagement with Patients, Providers, and Your Brand [Read More](https://blog.ubc.com/blog/drive-engagement-with-patients) [Case Study](https://blog.ubc.com/blog/tag/case-study) #### [A Large, Long-Term Disease Registry in Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS) Maximizes Patient Enrollment While Minimizing Site Burden](https://blog.ubc.com/blog/case-study-disease-registry-aml-mds) November 17, 2020 UBC is currently managing an AML / MDS disease registry for a leading biopharmaceutical client with 200 sites working toward an enrollment target of 2,100 patients... [Read More](https://blog.ubc.com/blog/case-study-disease-registry-aml-mds) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Strategies for Virtual and Decentralized Study Designs](https://blog.ubc.com/blog/virtual-and-decentralized-study-designs) October 8, 2020 In the wake of the COVID-19 health crisis, studies need solutions to remediate disruptions and ensure continuity of support for sites and patients participating in... [Read More](https://blog.ubc.com/blog/virtual-and-decentralized-study-designs) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Is Your Organization Pharmacovigilance Ready?](https://blog.ubc.com/blog/are-you-pv-ready) August 17, 2020 The right strategy to continually evaluate product safety in your clinical trials, through regulatory review and entering the post-marketing setting, is complex. Are you... [Read More](https://blog.ubc.com/blog/are-you-pv-ready) [Blog](https://blog.ubc.com/blog/tag/blog) #### [The Patient Advocate – A Critical Partner in Drug Development](https://blog.ubc.com/blog/the-patient-advocate-a-critical-partner-in-drug-development) October 2, 2019 Patients are the heart of clinical research. It is important to understand factors affecting the patient outside of the clinical trial setting to better understand the... [Read More](https://blog.ubc.com/blog/the-patient-advocate-a-critical-partner-in-drug-development) [Blog](https://blog.ubc.com/blog/tag/blog) #### [5 Areas in Adverse Event Reporting to Consider](https://blog.ubc.com/blog/5-areas-in-adverse-event-reporting-to-consider) March 14, 2019 Traditionally, sources of adverse event reporting included the clinical trial investigator sites, post-marketing medical information call centers, and local QPs in... [Read More](https://blog.ubc.com/blog/5-areas-in-adverse-event-reporting-to-consider) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Rare Disease Patients, Clinical Development, & Social Media](https://blog.ubc.com/blog/social-media-strategies-to-make-your-message-heard) October 2, 2017 The growth of social media interactions has played a critical role in advancing knowledge and awareness of orphan and rare orphan diseases. Social media tools have... [Read More](https://blog.ubc.com/blog/social-media-strategies-to-make-your-message-heard) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Successful Strategies in Patient Recruitment and Retention](https://blog.ubc.com/blog/leveraging-successful-strategies-in-patient-recruitment-and-retention) July 18, 2017 Ophthalmic Drug Development Summit: Pre-Conference Workshop [Read More](https://blog.ubc.com/blog/leveraging-successful-strategies-in-patient-recruitment-and-retention) [Blog](https://blog.ubc.com/blog/tag/blog) #### [Postmarketing Research: Ten Reasons to Plan Early](https://blog.ubc.com/blog/ten-reasons-to-plan-early-and-conduct-postmarketing-research) June 15, 2017 Manufacturers of biopharmaceutical products and medical devices understand that the regulatory approval of their product will bring postmarketing challenges, requiring... [Read More](https://blog.ubc.com/blog/ten-reasons-to-plan-early-and-conduct-postmarketing-research) ![Footer Logo](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-blue.jpg?width=113&name=logo-blue.jpg "Footer Logo") #### Quick Links - Subscribe to Think Tank - [Contact UBC](https://ubc.com/contact) - [Privacy](https://ubc.com/privacy-policy) - [Terms of Use](https://ubc.com/terms-of-use) - [Sitemap](https://ubc.com/sitemap) #### RECENT ARTICLES - [Planning for Diversity in Clinical Trials](https://blog.ubc.com/blog/planning-for-diversity-in-clinical-trials) - [Practical Considerations for Evidence Generation](https://blog.ubc.com/blog/practical-considerations-rwe) - [Supporting Patients and Families Through Case Management](https://blog.ubc.com/blog/supporting-patients-and-families-through-case-management) Copyright © 2017-2026 United BioSource LLC, all rights reserved. UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC. ![close button](https://blog.ubc.com/hubfs/close.png) ### Subscribe to Think Tank #### Look for more industry-related insight coming soon! Thank you for your interest in UBC’s thought leadership! ```json { "@context" : "https://schema.org", "@type" : "VideoObject", "caption" : { "@type" : "MediaObject", "contentUrl" : "https://blog.ubc.com/media-transcripts/86816294151/en.vtt", "inLanguage" : "en", "name" : "en Captions" }, "contentUrl" : "https://20923316.fs1.hubspotusercontent-na1.net/hubfs/20923316/Practical%20Considerations%20for%20RWE%20Generation.mp4", "dateModified" : "2025-11-10T18:12:25.619Z", "duration" : "PT2M59.435S", "height" : 1080, "name" : "Practical Considerations for RWE Generation", "thumbnailUrl" : "https://20923316.fs1.hubspotusercontent-na1.net/hubfs/20923316/Practical%20Considerations%20for%20RWE%20Generation.mp4/medium.jpg?t=1762798345619", "uploadDate" : "2022-10-03T16:12:03.535Z", "width" : 1920 } ``` ```json { "@context" : "https://schema.org", "@type" : "VideoObject", "caption" : { "@type" : "MediaObject", "contentUrl" : "https://blog.ubc.com/media-transcripts/86811304448/en.vtt", "inLanguage" : "en", "name" : "en Captions" }, "contentUrl" : "https://20923316.fs1.hubspotusercontent-na1.net/hubfs/20923316/Data%20Considerations%20for%20RWE%20Generation.mp4", "dateModified" : "2025-11-10T18:07:28.214Z", "duration" : "PT2M53.333S", "height" : 1080, "name" : "Data Considerations for RWE Generation", "thumbnailUrl" : "https://20923316.fs1.hubspotusercontent-na1.net/hubfs/20923316/Data%20Considerations%20for%20RWE%20Generation.mp4/medium.jpg?t=1762798048214", "uploadDate" : "2022-10-03T16:12:33.375Z", "width" : 1920 } ``` ```json { "@context" : "https://schema.org", "@type" : "VideoObject", "caption" : { "@type" : "MediaObject", "contentUrl" : "https://blog.ubc.com/media-transcripts/86815965057/en.vtt", "inLanguage" : "en", "name" : "en Captions" }, "contentUrl" : "https://20923316.fs1.hubspotusercontent-na1.net/hubfs/20923316/Technology%20Considerations%20for%20RWE%20Generation.mp4", "dateModified" : "2025-11-10T18:07:29.204Z", "duration" : "PT2M38.699S", "height" : 1080, "name" : "Technology Considerations for RWE Generation", "thumbnailUrl" : "https://20923316.fs1.hubspotusercontent-na1.net/hubfs/20923316/Technology%20Considerations%20for%20RWE%20Generation.mp4/medium.jpg?t=1762798049204", "uploadDate" : "2022-10-03T16:12:19.218Z", "width" : 1920 } ```